Among patients with metastatic disease, patients aged >10 years, with FP tumors, PAX3::FOXO1 fusion type and B/BM involvement, had significantly worse EFS and OS compared to patients aged ≤10 years, without B/BM involvement, FN tumors, or with PAX7::FOXO1 fusion type (Table 3). This evidence concerns the gene PAX3 and metastatic neoplasm.